Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Charles River Laboratories International, Inc. (CRL) had Normalized Pre-Tax Income of $93.11M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$4.05B |
|
$10.30M |
|
$2.72B |
|
$1.33B |
|
$3.82B |
|
$227.35M |
|
$-134.23M |
|
$93.11M |
|
|
Normalized Pre-Tax Income |
$93.11M |
$25.29M |
|
$25.29M |
|
$25.29M |
|
$25.29M |
|
$227.35M |
|
$804.09M |
|
51.38M |
|
51.63M |
|
$0.20 |
|
$0.20 |
|
| Balance Sheet Financials | |
$1.40B |
|
$1.60B |
|
$6.13B |
|
$7.53B |
|
$994.10M |
|
$2.24B |
|
$3.07B |
|
$4.06B |
|
$3.47B |
|
$-103.06M |
|
$3.47B |
|
51.14M |
|
| Cash Flow Statement Financials | |
$734.58M |
|
$-245.09M |
|
$-550.93M |
|
$284.48M |
|
$205.57M |
|
$-78.91M |
|
$69.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
0.39 |
|
0.65 |
|
32.88% |
|
5.61% |
|
5.61% |
|
19.85% |
|
2.30% |
|
0.25% |
|
$501.61M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
9.76 |
|
5.62 |
|
64.97 |
|
0.73% |
|
-24.54% |
|
0.34% |
|
0.44% |
|
$67.79 |
|
$9.72 |
|
$14.23 |
|